Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GenomeDx Biosciences

Explore full profile

Genomic information company headquartered in Vancouver, British Columbia, with laboratories in San Diego, California

Vancouver, CanadaFounded 2008Biotech & Life Sciences
Valuation $10–25M Last recorded · 2018
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for GenomeDx Biosciences and the history behind them.

About GenomeDx Biosciences

GenomeDx, through its Decipher genomic tests, specializes in providing advanced diagnostic solutions for urologic cancers. The company serves healthcare providers and patients by offering genomic tests that deliver precise diagnostic insights, aiding in the effective management and treatment of urologic cancers. Operating in the healthcare and biotechnology market, GenomeDx employs a business model that focuses on the development and commercialization of genomic tests. Revenue is generated through the sale of these tests to medical institutions and healthcare professionals. The company's core product, Decipher, is designed to improve patient outcomes by providing detailed genomic information that informs treatment decisions. Keywords: genomic tests, urologic cancers, patient care, diagnostic insights, healthcare providers, biotechnology, genomic information, treatment decisions, medical institutions, healthcare professionals.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Vancouver, Canada
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Calibrium
  • Robert W. Baird & Co.
  • Merck & Co.

Series B and later1 investor entered at this stage

  • CRG LP

Talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States96.5%
🇨🇦 Canada2.4%
🇬🇧 United Kingdom1.2%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GenomeDx Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GenomeDx Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles